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It had been noted previously that the activity of mitocho~dr~a~ dihydroorotat~ dehydrogenase was lower 
in crude tissue prep~ations containing cytosol than in isolated mitochondria. Closer examination reveals 
that the apparent lower enzyme activity is due to rapid conversion of newly-synthesized orotate to 
uridine~S-monophosphate by he cytosolic enzymes, orotate phosphoribosyltransferase and orotidylate 
decarboxylase. 
Dihydroorotate dehydrogenase Effect of cytosol Apparent inhibition 
&orate 
I< INTRODUCTION 
In eukaryatic cells, 5 of the 6 enzymes involved 
in the biosynthesis of pyrim~dines reside in the 
cytosol as two distinct compiexes f1,2]. The first 
complex contains 3 enzymes which catalyze the in- 
itial steps and the second complex contains the last 
2 enzymes of the pathway. Dihydroorotate 
dehydrogen~se ~DHO-~Hase~~ the fourth enzyme 
of the sequence, catalyzes the oxidatian of 
dihydroorotate to orotate. In eukaryotes this en- 
zyme is located in mitochondria [3,4] and is linked 
to the electron transport chain [5-71. 
formed have been used. These include spec- 
trophotometric quantitation of orotate [3J or 
radiometric assays based on the conversion of 
~4-*4CJdihydroorotic a id to f4-“dforotic acid and 
subsequent isolation of the product by dec- 
trophoretic [8] or chromatographic [1,9J 
procedures. 
Artificial eIectron acceptors are generally 
employed for dihydroorotate dehydrogenase 
assays but, because of competing reactions, they 
are unsatisfactory for use with crude tissue 
preparations. In the latter setting, methods based 
on direct quantitation of the amount of orotate 
Abbreviations: DHO-DHase, dihydroorotate dehydro- 
genase (EC 1.3.3.1); ODCase, orotidylate decarbaxylase 
(EC 4. I. L 23); OPRTase, orotate phosphoribo~yl- 
transferase (EC 2.4.2. IO); PRPP, 5-phosphoryf- 
ribose-l-pyrophosphate; UMP, uridine-S-mono- 
phosphate 
Previously, it had been reported that total 
dehydrogenase activity in isolated, intact 
mitochondria exceeded that in whole homogenates 
[3]. It was suggested that cytosol might contain an 
inhibitor of the mitochondrial enzyme. Subse- 
quently, the same observation was repeated and 
ascribed to conversion of dihydroorotate to 
carbamylaspartate by the enzyme, dihydroorotase, 
thereby making the concentration of dihydro- 
orotate rate-limiting for DH~-phase f IOJ. in both 
cases the assays were dependent on measurement 
of orotate accumulation. Here, we report that the 
lower activity of dihydroorotate dehydrogenase in 
the presence of cytosol appears to be due to rapid 
conversion of orotate to uridylic acid by two 
cytosolic enzymes, orotate phosphoribosy1~ 
transferase (OPRTase) and orotidylate decarbox- 
ylase (ODCase). 
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2. MATERIALS AND METHODS with each experimental condition. 
2.1. Materials 
L-dihydroorotate, phosphoribosylpyrophos- 
phate, erotic acid, yeast OPRTase, yeast ODCase, 
Tris, bacterial DHO-DHase (partially purified 
from Z. oroticum), crystalline yeast alcohol dehy- 
drogenase and other chemicals were obtained from 
Sigma. [carboxyl-‘4C]Orotic acid, Bray’s scintilla- 
tion solution and Aquasol 2 were purchased from 
New England Nuclear. L-5,6-[carboxyl-r4C]DH0 
was enzymatically prepared and purified by the 
method in [ll]. 
2.2. Preparation of rat liver mitochondrial 
particles and cytosol 
Livers from 150-200 g male Sprague-Dawley 
rats were homogenized in 9 volumes of 0.25 M 
sucrose, and mitochondria were isolated by cen- 
trifugation of the 600 x g supernatant at 8000 x g. 
The mitochondrial pellet was washed twice in 
0.15 M KC1 and suspended in 0.15 M Tris-HCI 
(pH 7.5) to l/3 of the original homogenate. The 
mitochondrial preparation was used immediately 
for experiments with intact mitochondria or frozen 
at - 20°C. The thawed mitochondrial particles 
were washed with 0.15 M Tris-HCl (pH 7.5), col- 
lected by centrifuging at 10000 x g for 15 min and 
resuspended in 0.15 M Tris-HCl (pH 7.5) to l/3 
of the volume of the original homogenate. 
For preparation of the cytosolic fraction, the 
post mitochondrial supernatant of the liver 
homogenate prepared in 0.15 M Tris-HCl (pH 
7.5) was centrifuged at 100000 x g for 60 min and 
the supernatant fraction was collected. 
The radiometric assay of DHO-DHase was car- 
ried out as in [II] with minor modifications. The 
usual incubation system contained: 100 mM 
Tris-HCl (pH 8.0), 5 mM MgC12, 0.5 mM 
phosphoribosylpyrophosphate (PRPP), 0.25 mM 
[carboxyl-i4C]DH0 (-250000 dpm/assay), 5 units 
orotate phosphoribosyltransferase, 5 units 
orotidylate decarboxylase and the mitochondrial 
preparation equivalent to 20-50 g protein in a 
final volume of 1 .O ml. The reactions were carried 
out in tightly closed Ehrlenmeyer flasks (25 ml) 
carrying 0.3 ml hyamine hydroxide in the suspend- 
ed center wells. The flasks were incubated at 30°C 
for 30 min in a metabolic shaker and the reaction 
was terminated by injecting 0.5 ml 1 N HC104. 
The flasks were incubated for an additional 1 h to 
ensure complete absorption of r4C02 by hyamine 
hydroxide. The center wells were transferred 
directly to the scintillation vials and the radioac- 
tivity determined in the presence of 10 ml scintilla- 
tion solution. When cytosolic fractions (prepared 
in 0.15 M Tris) were present, the final concentra- 
tion of Tris in the assay mixture was carefully ad- 
justed so as not to exceed 100 mM because higher 
concentrations of the salt inhibited the coupling 
enzymes. One unit of enzyme activity is defined as 
1 nmol of orotate or 1 nmol of CO2 formed in 
1 min. Protein was estimated as in [ 121. 
3. RESULTS AND DISCUSSION 
2.3. Assays of DHO-DHase 
Reaction mixture for the direct measurement of 
orotate formation contained: 100 mM Tris-HCl 
(pH S.O), 1 mM L-dihydroorotate, mitochondrial 
preparation equivalent o 200-500 pg protein and, 
when present, the specified amount of supernatant 
fraction in a final volume of 2 ml. The reaction 
was carried out at 37°C for 30 min (unless other- 
wise specified) with shaking and terminated by ad- 
dition of 2.0 ml of 2 N HC104. The concentration 
of orotate in the supernatant was measured by its 
absorbance at 280 nm [3] or at 290 nm as modified 
recently to avoid the absorbance due to UMP. 
Blanks without substrate were run concurrently 
Addition of 100000 x g supernatant from liver 
or brain caused an apparent dose-dependent 
decrease in DHO-DHase activity of mitochondrial 
particles when assayed spectrophotometrically 
(fig. 1). This finding confirms earlier reports [3, lo] 
with intact mitochondria. Substitution of partially 
purified dihydroorotase [13] for cytosol did not 
result in inhibition of dihydroorotate oxidation by 
isolated mitochondria (not shown), indicating that 
competition for DHO by DHO-DHase and the 
cytosolic dihydroorotase is not the cause of the ap- 
parent inhibition. Therefore, it was assumed that 
the decrease in orotate concentration in the 
presence of cytosol is due either to inhibition of 
DHO-DHase by some factor or factors present in 
the cytosol or due to partial loss of orotate as it is 
being produced. As indicated in table 1, the effect 
of cytosol on DHO-DHase could be abolished if 
2 
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Fig. f . Effect of IOOQOO x g supernatant fractions from 
liver or brain on the activity of dihydroor~tate 
dehydrog~~~e in liver &-----a) and brain (O---O) 
mito~bondr~a, respectivefy. The enzyme was assayed 
spectro~~otometricaily as described in section 2. Protein 
concentrations of liver and brain supernatant fractions 
were 19.3 mgfmI and 5.4 mg/ml, respectively. The 
indicated amounts of cytosoi were added at the 
beginning and the reaction was initiated by addition of 
substrate after 5 min pre-incubation. The activities of 
liver and brain enzymes in the absence of cytosol were 
5.32 and 1.83 units/me; protein, respectively. Each value 
given is the average of duplicate measurements. 
the supernatant fraction was either dialyzed or 
heated. This suggests that the cytosolic factor may 
be of small M, which itself is heat labile or, a small 
compound acting in concert with other heat IabiIe 
factors, 
In order to examine the nature of the apparent 
inhibition of DWO-DHase by cytosol, the enzyme 
was assayed as in ill]. This method measures the 
‘%ZQz release when fcarboxyl-‘4C]DH0 serves as 
substrate for the DHO-DHase reaction and the lat- 
ter is enzymatically coupled with large excess of 
purified OPRTase and ODCase. If the cytasol con- 
tained any inhibitors of DHO-DHase there would 
be less “CO~ produced, On the other hand, if the 
cytosol did not inhibit at the IeveI of Dam-DHase, 
there would not be any decrease in 14C02 produc- 
tion because the coupling enzymes will quan- 
titatively convert all orotate into UMP and 14C02. 
As evident from table 2 addition of cytosol did not 
bring about any change in the 14C02 production 
whereas the same amount of cytosol brought about 
marked decrease in DHO-DHase activity expressed 
in terms of orotate formed as measured 
s~e~trophotometri~ally. 
Cells contain orotate phos~hor~bosyltransf~r~se 
and orotidylate decarboxylase xisting as a com- 
plex (complex U) in the cytosol j1,14-175. These 
two enzymes catalyze the conversion of orotate to 
UMP and COZ in the presence of phosphoribosyl- 
pyrophosphate and Mg’+. Even though the com- 
plex contains two catalytic centers (orotate 
ph~sphoribosyltransferase and orotidylate decar- 
baxylase), the decarboxylase of the complex is suf- 
ficiently active so that stoichiometric production 
of orotidylic acid and PPi by the phosphoribosyl- 
transferase can only be observed if the decarbox- 
ylation is completely inhibited [lSj. Therefore, if 
there are sufficient concentrations of PRPP and 
Mg” present in the cytosoi, orotate formed by 
DHO-DHase of the mitochondria could get con- 
verted to UMP and CO2 by complex U. In order 
to examine this possibility, we studied the effect of 
Table I 
Effect of heat-treated or dialyzed 1~~ x g su~ernatant fraction on dihydroorotate dehydrogenase activity in 
mito~hondria~ particles 
Addition to the assay system DHO-DHase activity 
(units/mg protein) 
%I Decrease 
of activity 
None ~~ntro~~ 
Supernatant fraction 
Heat-treated supernatant fraction 
Dialyzed supernatant fraction 
4.15 
2.93 28 
4.20 O 
4.10 O 
DHO-DHase was assayed by the direct ob~rvat~on of the appearance of orotate by measuring its absorbance at 280 nm, 
Heat inactivation was carried out by heating the cytosol at 50°C for 15 min. Dialysis was carried out for 20 h at 4°C 
with 3 changes of buffer. Supernatant fraction present in each incubation was equivaIent to 6 mg cytosolic protein. 
Details of the assay system are given in section 2. Each value given is the mean of dupficate assays 
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Table 2 
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Comparison of the effect of 100000 x g supernatant fraction on dihydroorotate dehydrogenase activity determined by 
two different assay methods 
Method of assay DHO-DHase activity % Decrease 
(unit/mg protein) in activity 
- Supernatant + Supernatant 
Spectrophotometric determination of orotate 4.11 2.38 42 
Radiometric determination of CO2 release 3.88 3.93 0 
Details of the assay methods are given in section 2. Supernatant fraction present in each assay system was equivalent 
to 7-8 mg protein 
Table 3 
PRPP-dependent removal of orotate from the DHO-DHase assay system and its subsequent decarboxylation by liver 
cytosol 
Addition to the assay system Orotate recovered “CO2 recovered 
(nmol) (nmol) 
% Recovery of 
of products 
(orotate + CO2) 
None 28.49 0 100 
Cytosol 24.11 3.72 98 
Cytosol + PRPP, 0.05 mM 19.18 1.44 93 
Cytosol + PRPP, 0.1 mM 14.25 15.68 105 
Cytosol + PRPP, OS mM 4.38 22.14 93 
Cytosol + PRPP, 1.0 mM 0 30.35 106 
The control assay mixture contained 100 mM Tris-HCl (pH 8.0), [carboxyl-‘4C], 0.5 mM DHO (257 dpm~nmol), 
5 mM MgClz, intact liver mitochondria equivalent o 0.31 mg protein and, when present, cytosol equivalent to 5.31 mg 
protein and the indicated concentrations of PRPP in a final volume of 2 ml. Incubation was carried out in tightly sealed 
Erlenmeyer flasks at 37°C for 20 min. 14C02 released was trapped in 0.3 ml hyamine hydroxide. Incubation was 
terminated by addition of 2 ml 2 N HCQ and the concentration of orotate was determined by the UV absorbance at 
290 nm. Each value given is the mean of duplicate observations 
liver cytosol on the DHO-DHase assay in the 
presence of added PRPP and without the addition 
of exogenous complex U enzymes. In this experi- 
ment we used ~carboxyl-‘*C]DHO as substrate and 
simultaneously measured orotate formation and 
14C02 release. As shown in table 3, the amount of 
orotate recovered was inversely related to the 
PRPP concentration. The disappearance of 
orotate resulted in an equivalent increase in the ap- 
pearance of 14COz. indicating that orotate can be 
rapidly converted to UMP and CO2 in this system 
provided sufficient PRPP and MgZf are present. 
In table 3 the decrement in absorbance with 
cytosol alone was somewhat less than is usually 
seen. In this regard, we have noted considerable 
4 
variability from one cytosol preparation to 
another. This may reflect different concentrations 
of labile substrate, PRPP, in different cytosol 
preparations. 
Based on the foregoing, several points bear 
emphasis: 
(1) When orotate formation is measured directly, 
the ‘apparent’ reduction in mitochondrial 
orotate synthesis in the presence of cytosol is 
due to conversion of orotate to UMP by 
cytosolic enzymes. Cytosol does not contain 
an inhibitor of DHO-DHase, nor does 
cytosolic dihydroorotase reduce dihydrooro- 
tate levels to the point that they become rate- 
limiting for DHO-DHase. 
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(2) 
(3) 
When assaying DHO-DHase in crude tissue 
preparations containing cytosol, the method 
of assay must be selected with care. The assay 
system in [ 1 l] appears to be best suited for this 
purpose. 
Orotate produced by mitochondrial DHO- 
DHase is converted to UMP by cytosolic en- 
zymes in a highly efficient manner. As shown 
in table 3, addition of a sufficient amount of 
PRPP results in stoichiometric conversion of 
newly synthesized orotate to UMP as 
measured by CO2 production. 
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